NDC11 65517000201
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 65517-0002-01 | 65517-0002 |
| 65517-0002-1 | 65517-0002 |
| 65517-002-01 | 65517-002 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Adalimumab-ryvk | ADALIMUMAB-RYVK | Teva Pharmaceuticals USA, Inc. | f8c0d3c2-b5ed-4bb8-927c-5c5529343ee6 | 2026-03-03 | Boxed warning, Warnings, Adverse reactions | 65517-0002-1 65517000201 |
| Adalimumab-ryvk | ADALIMUMAB-RYVK | Quallent Pharmaceuticals Health LLC | dce1590f-9e47-4c4d-9437-cfb18b779a75 | 2026-01-19 | Boxed warning, Warnings, Adverse reactions | 65517-0002-1 65517000201 |
| Adalimumab-ryvk | ADALIMUMAB-RYVK | Teva Pharmaceuticals USA, Inc. | 2d19a877-1f5a-4731-800a-dddadc424080 | 2025-12-31 | Boxed warning, Warnings, Adverse reactions | 65517-0002-1 65517000201 |
| Simlandi | ADALIMUMAB-RYVK | Teva Pharmaceuticals USA, Inc. | 12f609c9-2088-bb05-e063-6394a90a9ecc | 2025-10-31 | Boxed warning, Warnings, Adverse reactions | 65517-0002-1 65517000201 |
| Simlandi | ADALIMUMAB-RYVK | A-S Medication Solutions | ba9dd71c-13c9-4cfe-84a2-b4f17d1c583f | 2025-10-16 | Boxed warning, Warnings, Adverse reactions | 65517-0002-1 65517000201 |
| Dukal Sterile Alcohol Prep Pad | ISOPROPYL ALCOHOL | Dukal LLC | 00b2c444-8601-4d8f-b6bb-91b864fd9041 | 2025-04-23 | Warnings | 65517-0002-1 65517-0002 65517000201 |
| Dukal Sterile Alcohol Prep Pad | ISOPROPYL ALCOHOL | Dukal Corporation | 54586d75-a0a1-46aa-9cc9-631094320bff | 2019-02-28 | Warnings | 65517-0002 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.